Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fierce Pharma
Stealth scores FDA approval for 1st Barth syndrome treatment
Stealth’s injection will be sold as Forzinity for Barth syndrome, an X-linked genetic disorder that weakens the heart and other muscles.
Gabrielle Masson
Sep 19, 2025 6:00pm
What’s next for Roche’s expensive obesity pipeline?
Sep 19, 2025 10:16am
One-third of data collected in trials may be unnecessary: study
Sep 19, 2025 11:01am
Fierce Pharma
ACIP narrowly votes against COVID vaccine prescriptions
Sep 19, 2025 5:22pm
Medtronic ankle implant approved for urinary incontinence
Sep 19, 2025 12:00pm
Exactech to pay $8M to settle defective knee implant lawsuits
Sep 19, 2025 11:20am
More News
Japan biotech inks RNA research pact that includes mRNA compounds
Sep 19, 2025 10:49am
CatalYm catalyzes C-suite shake-up—Chutes & Ladders
Sep 19, 2025 8:30am
Fierce Pharma
RFK Jr.'s ACIP delivers perplexing vote on MMRV vaccine guidance
Sep 18, 2025 6:33pm
Biotech veteran Robert Langer joins son launching new VC
Sep 18, 2025 3:15pm
See more stories